Axonics Modulation Technologies Stock Performance
| AXNX Stock | USD 70.28 0.01 0.01% |
Axonics Modulation has a performance score of 13 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0884, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Axonics Modulation's returns are expected to increase less than the market. However, during the bear market, the loss of holding Axonics Modulation is expected to be smaller as well. Axonics Modulation right now shows a risk of 0.24%. Please confirm Axonics Modulation value at risk, as well as the relationship between the kurtosis and price action indicator , to decide if Axonics Modulation will be following its price patterns.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Axonics Modulation Technologies are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Axonics Modulation is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.03) | Five Day Return (0.04) | Year To Date Return 17.69 | Ten Year Return 369.09 | All Time Return 369.09 |
1 | Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | 08/09/2024 |
2 | Disposition of 2597 shares by Kari Keese of Axonics Modulation at 69.4066 subject to Rule 16b-3 | 10/02/2024 |
3 | Axonics, Inc. Strong Growth and Global Momentum in 2024 | 10/14/2024 |
| Begin Period Cash Flow | 238.8 M | |
| Free Cash Flow | -5.6 M |
Axonics |
Axonics Modulation Relative Risk vs. Return Landscape
If you would invest 6,849 in Axonics Modulation Technologies on July 26, 2024 and sell it today you would earn a total of 178.00 from holding Axonics Modulation Technologies or generate 2.6% return on investment over 90 days. Axonics Modulation Technologies is currently generating 0.041% in daily expected returns and assumes 0.2388% risk (volatility on return distribution) over the 90 days horizon. In different words, 2% of stocks are less volatile than Axonics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Axonics Modulation Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axonics Modulation's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axonics Modulation Technologies, and traders can use it to determine the average amount a Axonics Modulation's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1718
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AXNX |
Estimated Market Risk
| 0.24 actual daily | 2 98% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Axonics Modulation is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axonics Modulation by adding it to a well-diversified portfolio.
Axonics Modulation Fundamentals Growth
Axonics Stock prices reflect investors' perceptions of the future prospects and financial health of Axonics Modulation, and Axonics Modulation fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axonics Stock performance.
| Return On Equity | -0.0028 | ||||
| Return On Asset | -0.0046 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 3.28 B | ||||
| Shares Outstanding | 51.12 M | ||||
| Price To Earning | (10.68) X | ||||
| Price To Book | 5.58 X | ||||
| Price To Sales | 8.79 X | ||||
| Revenue | 366.38 M | ||||
| Gross Profit | 197.66 M | ||||
| EBITDA | 8.68 M | ||||
| Net Income | (6.09 M) | ||||
| Cash And Equivalents | 213.23 M | ||||
| Cash Per Share | 4.53 X | ||||
| Total Debt | 27.62 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 10.49 X | ||||
| Book Value Per Share | 12.61 X | ||||
| Cash Flow From Operations | (2.02 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Market Capitalization | 3.59 B | ||||
| Total Asset | 719.92 M | ||||
| Retained Earnings | (380.35 M) | ||||
| Working Capital | 445.61 M | ||||
| Current Asset | 171.14 M | ||||
| Current Liabilities | 12.98 M | ||||
About Axonics Modulation Performance
Evaluating Axonics Modulation's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Axonics Modulation has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Axonics Modulation has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 289.21 | 274.75 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Axonics Modulation performance evaluation
Checking the ongoing alerts about Axonics Modulation for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axonics Modulation help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 366.38 M. Net Loss for the year was (6.09 M) with profit before overhead, payroll, taxes, and interest of 197.66 M. | |
| Axonics Modulation Technologies currently holds about 213.23 M in cash with (2.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.53. | |
| Axonics Modulation has a poor financial position based on the latest SEC disclosures | |
| Over 86.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 |
- Analyzing Axonics Modulation's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axonics Modulation's stock is overvalued or undervalued compared to its peers.
- Examining Axonics Modulation's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axonics Modulation's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axonics Modulation's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axonics Modulation's stock. These opinions can provide insight into Axonics Modulation's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Axonics Stock Analysis
When running Axonics Modulation's price analysis, check to measure Axonics Modulation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics Modulation is operating at the current time. Most of Axonics Modulation's value examination focuses on studying past and present price action to predict the probability of Axonics Modulation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics Modulation's price. Additionally, you may evaluate how the addition of Axonics Modulation to your portfolios can decrease your overall portfolio volatility.